CALCULATION
OF REGISTRATION FEE
Title of Each Class of Securities
Offered
|
|
Maximum Aggregate
Offering Price
|
|
Amount of Registration
Fee
|
Buffered
Performance Leveraged Upside Securities due 2021
|
|
$500,000
|
|
$60.60
|
June
2019
Pricing
Supplement No. 2,149
Registration
Statement Nos. 333-221595; 333-221595-01
Dated
June 12, 2019
Filed
pursuant to Rule 424(b)(2)
M
organ
S
tanley
F
inance
LLC
Structured Investments
Opportunities in International Equities
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Fully and Unconditionally Guaranteed by Morgan Stanley
Principal at Risk
Securities
The Buffered PLUS are unsecured
obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley.
The Buffered PLUS will pay no interest, provide a minimum payment at maturity of only 10% of the stated principal amount and have
the terms described in the accompanying product supplement for PLUS, index supplement and prospectus, as supplemented or modified
by this document. At maturity, if the underlying shares have appreciated in value, investors will receive the stated principal
amount of their investment plus leveraged upside performance of the underlying shares, subject to the maximum payment at maturity.
If the underlying shares have depreciated in value, but the underlying shares have not declined by more than the specified buffer
amount, the Buffered PLUS will redeem for par. However, if the underlying shares have declined by more than the buffer amount,
investors will lose 1% for every 1% decline beyond the specified buffer amount, subject to the
minimum payment at maturity
of 10% of the stated principal amount. Investors may lose up to 90% of the stated principal amount of the Buffered PLUS.
The
Buffered PLUS are for investors who seek an equity fund-based return and who are willing to risk their principal and forgo current
income and upside above the maximum payment at maturity in exchange for the leverage and buffer features that in each case apply
to a limited range of performance of the underlying shares. The Buffered PLUS are notes issued as part of MSFL’s Series
A Global Medium-Term Notes program.
All payments are subject to
our credit risk. If we default on our obligations, you could lose some or all of your investment. These Buffered PLUS are not
secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference
asset or assets.
FINAL TERMS
|
Issuer:
|
Morgan Stanley Finance LLC
|
Guarantor:
|
Morgan Stanley
|
Maturity date:
|
June 16, 2021
|
Underlying shares:
|
Shares of the iShares
®
MSCI Emerging
Markets ETF (the “Fund”)
|
Aggregate principal
amount:
|
$500,000
|
Payment at maturity
per Buffered PLUS:
|
§
If
the final share price is
greater than
the initial share price:
$1,000 + leveraged upside payment
In
no event will the payment at maturity exceed the maximum payment at maturity.
|
|
§
If
the final share price is
less than or equal to
the initial share price but has decreased from the initial share price
by an amount less than or equal to the buffer amount of 10%: $1,000
|
|
§
If
the final share price is
less than
the initial share price and has decreased from the initial share price by an amount
greater than
the buffer amount of 10%:
|
|
($1,000
x the share performance factor) + $100
|
|
Under these
circumstances, the payment at maturity will be less than the stated principal amount of $1,000.
However,
under no circumstances will the Buffered PLUS pay less than $100 per Buffered PLUS at maturity.
|
Leveraged upside payment:
|
$1,000 x leverage factor x share percent increase
|
Share percent increase:
|
(final share price – initial share price)
/ initial share price
|
Share performance factor:
|
final share price / initial share price
|
Initial share price:
|
$42.08, which is the closing price of one underlying
share on June 11, 2019
|
Final share price:
|
The closing price of one underlying share on the
valuation date
times
the adjustment factor on such date
|
Adjustment factor:
|
1.0, subject to adjustment in the event of certain
events affecting the underlying shares
|
Valuation date:
|
June 11, 2021, subject to postponement for non-trading
days and certain market disruption events
|
Leverage factor:
|
200%
|
Buffer amount:
|
10%. As a result of the buffer amount
of 10%, the value at or above which the underlying shares must close on the valuation date so that investors do not suffer
a loss on their initial investment in the Buffered PLUS is $37.872, which is 90% of the initial share price.
|
Minimum payment at
maturity:
|
$100 per Buffered PLUS (10% of the stated principal
amount)
|
Maximum
payment at maturity:
|
$1,260 per Buffered PLUS (126% of the stated principal
amount)
|
Interest:
|
None
|
Stated principal amount:
|
$1,000 per Buffered PLUS
|
Issue price:
|
$1,000 per Buffered PLUS
|
Pricing date:
|
June 12, 2019
|
Original issue date:
|
June 17, 2019 (3 business days after the pricing
date)
|
CUSIP:
|
61769HHC2
|
ISIN:
|
US61769HHC25
|
Listing:
|
The Buffered PLUS will not be listed on any securities
exchange.
|
Agent:
|
Morgan Stanley & Co. LLC (“MS &
Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information
regarding plan of distribution; conflicts of interest.”
|
Estimated value on the pricing date:
|
$986.20 per Buffered PLUS of that estimate. See
“Investment Summary” on page 2.
|
Commissions
and issue price:
|
Price to
public
|
Agent’s
commissions
(1)
|
Proceeds
to us
(2)
|
Per Buffered PLUS
|
$1,000
|
$5
|
$995
|
Total
|
$500,000
|
$2,500
|
$497,500
|
|
(1)
|
Selected dealers and
their financial advisors will collectively receive from the agent, MS & Co., a fixed sales commission of $5 for each Buffered
PLUS they sell. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional
information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement for PLUS.
|
|
(2)
|
See “Use of proceeds
and hedging” on page 17.
|
The Buffered
PLUS involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on
page 6.
The Securities
and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this
document or the accompanying product supplement, index supplement and prospectus is truthful or complete. Any representation to
the contrary is a criminal offense.
The Buffered
PLUS are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental
agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.
You should
read this document together with the related product supplement, index supplement and prospectus, each of which can be accessed
via the hyperlinks below. Please also see “Additional Terms of the Buffered PLUS” and “Additional Information
About the Buffered PLUS” at the end of this document.
As used in
this document, “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and
MSFL collectively, as the context requires.
Product
Supplement for PLUS dated November 16, 2017
Index
Supplement dated November 16, 2017
Prospectus
dated November 16, 2017
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
Investment Summary
Buffered Performance Leveraged Upside Securities
Principal
at Risk Securities
The Buffered PLUS Based on the iShares
®
MSCI Emerging
Markets ETF due June 16, 2021 (the “Buffered PLUS”) can be used:
|
§
|
As an alternative to direct exposure to the underlying shares that enhances returns for a certain
range of positive performance of the underlying shares, subject to the maximum payment at maturity
|
|
§
|
To enhance returns and potentially outperform the underlying shares in a moderately bullish scenario
|
|
§
|
To achieve similar levels of upside exposure to the underlying shares as a direct investment,
subject to the maximum payment at maturity, while using fewer dollars by taking advantage of the leverage factor
|
|
§
|
To obtain a buffer against a specified level of negative performance in the underlying shares
|
Maturity:
|
Approximately 2 years
|
Leverage
factor:
|
200%
|
Maximum
payment at maturity:
|
$1,260 per Buffered PLUS (126% of the stated principal amount)
|
Minimum
payment at maturity:
|
$100 per Buffered PLUS (10% of the stated principal amount). Investors may lose up to 90% of the stated principal amount of the Buffered PLUS.
|
Buffer
amount:
|
10%
|
Coupon:
|
None
|
The original issue price of each Buffered PLUS is $1,000. This
price includes costs associated with issuing, selling, structuring and hedging the Buffered PLUS, which are borne by you, and,
consequently, the estimated value of the Buffered PLUS on the pricing date is less than $1,000. We estimate that the value of each
Buffered PLUS on the pricing date is $986.20.
What goes into the estimated value on the pricing date?
In valuing the Buffered PLUS on the pricing date, we take into
account that the Buffered PLUS comprise both a debt component and a performance-based component linked to the underlying shares.
The estimated value of the Buffered PLUS is determined using our own pricing and valuation models, market inputs and assumptions
relating to the underlying shares, instruments based on the underlying shares, volatility and other factors including current and
expected interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest
rate at which our conventional fixed rate debt trades in the secondary market.
What determines the economic terms of the Buffered PLUS?
In determining the economic terms of the Buffered PLUS, including
the leverage factor, the maximum payment at maturity, the buffer amount and the minimum payment at maturity, we use an internal
funding rate, which is likely to be lower than our secondary market credit spreads and therefore advantageous to us. If the issuing,
selling, structuring and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the
economic terms of the Buffered PLUS would be more favorable to you.
What is the relationship between the estimated value on the
pricing date and the secondary market price of the Buffered PLUS?
The price at which MS & Co. purchases the Buffered PLUS in
the secondary market, absent changes in market conditions, including those related to the underlying shares, may vary from, and
be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market
credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and
other factors. However, because the costs associated with issuing, selling, structuring and hedging the Buffered PLUS are not fully
deducted upon issuance, for a period of up to 6 months following the issue date, to the extent that MS & Co. may buy or sell
the Buffered PLUS in the secondary market, absent changes in market conditions, including those related to the underlying shares,
and to our secondary market credit spreads, it would do so based on values higher than the estimated value. We expect that those
higher values will also be reflected in your brokerage account statements.
MS & Co. may, but is not obligated to, make a market in the
Buffered PLUS, and, if it once chooses to make a market, may cease doing so at any time.
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
Key Investment Rationale
The Buffered PLUS offer leveraged upside exposure to the underlying
shares, subject to the maximum payment at maturity, while providing limited protection against negative performance of the underlying
shares. Once the underlying shares have decreased in price by more than a specified buffer amount, investors are exposed to the
negative performance of the underlying shares, subject to the minimum payment at maturity. At maturity, if the underlying shares
have appreciated, investors will receive the stated principal amount of their investment plus leveraged upside performance of the
underlying shares, subject to the maximum payment at maturity. At maturity, if the underlying shares have depreciated and (i) if
the closing price of the underlying shares has not declined from the initial share price by more than the specified buffer amount,
the Buffered PLUS will redeem for par, or (ii) if the closing price of the underlying shares has declined by more than the buffer
amount, the investor will lose 1% for every 1% decline beyond the specified buffer amount, subject to the minimum payment at maturity.
Investors may lose up to 90% of the stated principal amount of the Buffered PLUS.
Leveraged
Performance up to a Cap
|
The Buffered PLUS offer investors an opportunity to capture enhanced returns for a certain range of positive performance relative to a direct investment in the underlying shares, subject to the maximum payment at maturity.
|
Upside
Scenario
|
The underlying shares increase in price, and, at maturity, the Buffered PLUS redeem for the stated principal amount of $1,000 plus 200% of the share return, subject to the maximum payment at maturity of $1,260 per Buffered PLUS (126% of the stated principal amount).
|
Par
Scenario
|
The underlying shares decline in price by no more than 10%, and, at maturity, the Buffered PLUS redeem for the stated principal amount of $1,000.
|
Downside
Scenario
|
The underlying shares decline in price by more than 10%, and, at maturity, the Buffered PLUS redeem for less than the stated principal amount by an amount that is proportionate to the percentage decrease of the underlying shares from the initial share price, plus the buffer amount of 10%. (Example: if the underlying shares decrease in price by 35%, investors would lose 25% of their principal and the Buffered PLUS will redeem for $750.00, or 75% of the stated principal amount.) The minimum payment at maturity is $100 per Buffered PLUS.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
How the Buffered PLUS Work
Payoff Diagram
The payoff diagram below illustrates the payment at maturity
on the Buffered PLUS based on the following terms:
Stated
principal amount:
|
$1,000 per Buffered PLUS
|
Leverage factor:
|
200%
|
Buffer amount:
|
10%
|
Maximum payment
at maturity:
|
$1,260 per Buffered PLUS (126% of the stated principal amount)
|
Minimum payment
at maturity:
|
$100 per Buffered PLUS
|
Buffered PLUS Payoff Diagram
|
|
How it works
|
§
|
Upside Scenario.
If the final share
price is greater than the initial share price, investors will receive the $1,000 stated principal amount plus 200% of the appreciation
of the underlying shares over the term of the Buffered PLUS, subject to the maximum payment at maturity. An investor will realize
the maximum payment at maturity of $1,260 per Buffered PLUS (126% of the stated principal amount) at a final share price of 113%
of the initial share price.
|
|
§
|
If the value of the underlying shares appreciates 2%, the investor would receive a 4% return,
or $1,040.00 per Buffered PLUS.
|
|
§
|
If the value of the underlying shares appreciates 40%, the investor would receive only the maximum
payment at maturity of $1,260 per Buffered PLUS, or 126% of the stated principal amount.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
|
§
|
Par Scenario.
If the final share
price is less than or equal to the initial share price but has decreased from the initial share price by an amount less than or
equal to the buffer amount of 10%, investors will receive the stated principal amount of $1,000 per Buffered PLUS.
|
|
§
|
Downside Scenario.
If the final share
price is less than the initial share price and has decreased from the initial share price by an amount greater than the buffer
amount of 10%, investors will receive an amount that is less than the stated principal amount by an amount that is proportionate
to the percentage decrease in the value of the underlying shares from the initial share price, plus the buffer amount of 10%. The
minimum payment at maturity is $100 per Buffered PLUS.
|
|
§
|
For example, if the value of the underlying shares depreciates 45%, investors would lose 35%
of their principal and receive only $650.00 per Buffered PLUS at maturity, or 65% of the stated principal amount.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
Risk Factors
The following is a non-exhaustive list of certain key risk
factors for investors in the Buffered PLUS. For further discussion of these and other risks, you should read the section entitled
“Risk Factors” in the accompanying product supplement for PLUS, index supplement and prospectus. You should also consult
with your investment, legal, tax, accounting and other advisers in connection with your investment in the Buffered PLUS.
|
§
|
Buffered PLUS do not pay interest and provide a minimum payment at maturity of only 10% of your principal.
The terms
of the Buffered PLUS differ from those of ordinary debt securities in that the Buffered PLUS do not pay interest, and provide a
minimum payment at maturity of only 10% of the stated principal amount of the Buffered PLUS, subject to our credit risk. If the
final share price is less than 90% of the initial share price, you will receive for each Buffered PLUS that you hold a payment
at maturity that is less than the stated principal amount of each Buffered PLUS by an amount proportionate to the decline in the
closing value of the underlying shares from the initial share price, plus $100 per Buffered PLUS.
Accordingly, investors may
lose up to 90% of the stated principal amount of the Buffered PLUS.
|
|
§
|
The appreciation potential of the Buffered PLUS is limited by the maximum payment at maturity.
The appreciation potential
of the Buffered PLUS is limited by the maximum payment at maturity of $1,260 per Buffered PLUS, or 126% of the stated principal
amount. Although the leverage factor provides 200% exposure to any increase in the final share price over the initial share price,
because the payment at maturity will be limited to 126% of the stated principal amount for the Buffered PLUS, any increase in the
final share price over the initial share price by more than 13% of the initial share price will not further increase the return
on the Buffered PLUS.
|
|
§
|
The market price of the Buffered PLUS will be influenced by many unpredictable factors.
Several
factors, many of which are beyond our control, will influence the value of the Buffered PLUS in the secondary market and the price
at which MS & Co. may be willing to purchase or sell the Buffered PLUS in the secondary market, including the trading price,
volatility (frequency and magnitude of changes in value) and dividends of the underlying shares and of the stocks composing
the
MSCI Emerging Markets Index
SM
,
interest and yield
rates in the market, time remaining until the Buffered PLUS mature,
geo
political conditions
and economic, financial, political, regulatory or judicial events that affect the underlying shares or equities markets generally
and which may affect the final share price of the underlying shares, the exchange rates relative to the U.S. dollar with respect
to each of the currencies in which the shares comprising the MSCI Emerging Markets Index
SM
trade, the occurrence of certain events affecting the underlying shares that may or may not require
an adjustment to the adjustment factor, and any actual or anticipated changes in our credit ratings or credit spreads. The price
of the underlying shares may be, and has recently been, volatile, and we can give you no assurance that the volatility will lessen.
See “
iShares
®
MSCI Emerging Markets ETF
Overview” below. You
may receive less, and possibly significantly less, than the stated principal amount per Buffered PLUS if you try to sell your Buffered
PLUS prior to maturity.
|
|
§
|
The Buffered PLUS are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit
spreads may adversely affect the market value of the Buffered PLUS.
You are dependent on our ability to pay all amounts due
on the Buffered PLUS at maturity and therefore you are subject to our credit risk. If we default on our obligations under the Buffered
PLUS, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the
Buffered PLUS prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any actual or anticipated
decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit risk is likely to adversely
affect the market value of the Buffered PLUS.
|
|
§
|
As a finance subsidiary, MSFL has no independent operations and will have no independent assets.
As a finance subsidiary,
MSFL has no independent operations beyond the issuance and administration of its securities and will have no independent assets
available for distributions to holders of MSFL securities if they make claims in respect of such securities in a bankruptcy, resolution
or similar proceeding. Accordingly, any recoveries by such holders will be limited to those available under the related guarantee
by Morgan Stanley and that guarantee will rank
pari passu
with all other unsecured, unsubordinated obligations of Morgan
Stanley. Holders will have recourse only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of
securities issued by MSFL should accordingly assume that in any such proceedings they would not have any priority over and should
be treated
pari passu
with the claims of other unsecured, unsubordinated creditors of Morgan Stanley, including holders
of Morgan Stanley-issued securities.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
|
§
|
The amount payable on the Buffered PLUS is not linked to the value of the underlying shares at any time other than the valuation
date.
The final share price will be based on the closing price on the valuation date, subject to postponement for non-trading
days and certain market disruption events. Even if the value of the underlying shares appreciates prior to the valuation date but
then drops by the valuation date by more than 10%, the payment at maturity will be less, and may be significantly less, than it
would have been had the payment at maturity been linked to the value of the underlying shares prior to such drop. Although the
actual value of the underlying shares on the stated maturity date or at other times during the term of the Buffered PLUS may be
higher than the closing price on the valuation date, the payment at maturity will be based solely on the closing price on the valuation
date.
|
|
§
|
Investing in the Buffered PLUS is not equivalent to investing in the underlying shares or the stocks composing the MSCI
Emerging Markets Index
SM
.
Investing
in the Buffered PLUS is not equivalent to investing in the underlying shares, the
MSCI Emerging Markets Index
SM
(the “share underlying index”) or the stocks that constitute the
MSCI Emerging
Markets Index
SM
. Investors in the Buffered PLUS
will not have voting rights or rights to receive dividends or other distributions or any other rights with respect to the underlying
shares or the stocks that constitute the
MSCI Emerging Markets Index
SM
.
|
|
§
|
The price of the underlying shares is subject to currency exchange risk.
Because the
price of the underlying shares is related to the U.S. dollar value of stocks underlying the
MSCI Emerging Markets Index
SM
,
holders of the Buffered PLUS will be exposed to currency exchange rate risk with respect to each of the currencies in which such
component securities trade. Exchange rate movements for a particular currency are volatile and are the result of numerous factors
including the supply of, and the demand for, those currencies, as well as relevant government policy, intervention or actions,
but are also influenced significantly from time to time by political or economic developments, and by macroeconomic factors and
speculative actions related to the relevant region. An investor’s net exposure will depend on the extent to which the currencies
of the component securities strengthen or weaken against the U.S. dollar and the relative weight of each currency. If, taking into
account such weighting, the dollar strengthens against the currencies of the component securities represented in the
MSCI
Emerging Markets Index
SM
, the price of the underlying
shares will be adversely affected and the payment at maturity on the Buffered PLUS may be reduced.
|
Of
particular importance to potential currency exchange risk are:
|
·
|
existing and expected rates of inflation;
|
|
·
|
existing and expected interest rate levels;
|
|
·
|
the balance of payments; and
|
|
·
|
the extent of governmental surpluses or deficits in the countries represented in the MSCI
Emerging Markets Index
SM
and the United
States.
|
All
of these factors are in turn sensitive to the monetary, fiscal and trade policies pursued by the governments of various countries
represented in the MSCI Emerging Markets Index
SM
and
the United States and other countries important to international trade and finance.
|
§
|
There are risks associated with investments in securities, such as the Buffered PLUS, linked to the value of foreign (and
especially emerging markets) equity securities.
The underlying shares track the performance of the MSCI Emerging
Markets
Index
SM
, which is linked to the value of foreign (and especially emerging markets) equity securities. Investments
in securities linked to the value of foreign equity securities involve risks associated with the securities markets in those countries,
including risks of volatility in those markets, governmental intervention in those markets and cross-shareholdings in companies
in certain countries. Also, there is generally less publicly available information about foreign companies than about U.S. companies
that are subject to the reporting requirements of the Securities and Exchange Commission, and foreign companies are subject to
accounting, auditing and financial reporting standards and requirements different from those applicable to U.S. reporting companies.
The prices of securities issued in foreign markets may be affected by political, economic, financial and social factors in those
countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws. In addition,
the stocks included in the MSCI Emerging
Markets Index
SM
and that are generally
tracked by the underlying shares have been issued by companies in various emerging markets countries, which pose further risks
in addition to the risks associated with investing in foreign equity markets generally. Countries with emerging markets may have
relatively unstable governments, may present the
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
risks of nationalization of businesses,
restrictions on foreign ownership and prohibitions on the repatriation of assets, and may have less protection of property rights
than more developed countries. The economies of countries with emerging markets may be based on only a few industries, may be highly
vulnerable to changes in local or global trade conditions, and may suffer from extreme and volatile debt burdens or inflation rates.
Local securities markets may trade a small number of securities and may be unable to respond effectively to increases in trading
volume, potentially making prompt liquidation of holdings difficult or impossible at times. Moreover, the economies in such countries
may differ unfavorably from the economy in the United States in such respects as growth of gross national product, rate of inflation,
capital reinvestment, resources, self-sufficiency and balance of payment positions between countries.
|
§
|
Adjustments to the underlying shares or to the MSCI Emerging Markets Index
SM
could adversely affect the value of the Buffered PLUS.
As the investment adviser to the
iShares
®
MSCI Emerging Markets ETF, BlackRock Fund Advisors
(the “Investment Adviser”),
seeks
investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Emerging
Markets Index
SM
. Pursuant to its investment
strategy or otherwise, the Investment Adviser may add, delete or substitute the stocks composing the iShares
®
MSCI
Emerging Markets ETF. Any of these actions could adversely affect the price of the underlying shares and, consequently, the value
of the Buffered PLUS. MSCI Inc. (“MSCI”) is responsible for calculating and maintaining the MSCI Emerging Markets Index
SM
.
MSCI may add, delete or substitute the stocks constituting the MSCI Emerging Markets Index
SM
or make other methodological changes that could change the value of the MSCI Emerging Markets
Index
SM
.
MSCI may discontinue or
suspend calculation or publication of the
MSCI Emerging Markets Index
at any time. In
these circumstances, the calculation agent will have the sole discretion to substitute a successor index that is comparable to
the discontinued
MSCI Emerging Markets Index
SM
and is permitted to consider indices that are calculated and published by the calculation agent or any of its affiliates.
|
|
§
|
The performance and market price of the Fund, particularly during periods of market volatility, may not correlate with the
performance of the share underlying index, the performance of the component securities of the share underlying index or the net
asset value per share of the Fund.
The Fund does not fully replicate the share underlying index and may hold securities
that are different than those included in the share underlying index. In addition, the performance of the Fund will reflect
additional transaction costs and fees that are not included in the calculation of the share underlying index. All of these
factors may lead to a lack of correlation between the performance of the Fund and the share underlying index. In addition,
corporate actions (such as mergers and spin-offs) with respect to the equity securities underlying the Fund may impact the variance
between the performances of the Fund and the share underlying index. Finally, because the shares of the Fund are traded on
an exchange and are subject to market supply and investor demand, the market price of one share of the Fund may differ from
the net asset value per share of the Fund.
|
In particular, during periods of
market volatility, or unusual trading activity, trading in the securities underlying the Fund may be disrupted or limited, or such
securities may be unavailable in the secondary market. Under these circumstances, the liquidity of the Fund may be adversely
affected, market participants may be unable to calculate accurately the net asset value per share of the Fund, and their ability
to create and redeem shares of the Fund may be disrupted. Under these circumstances, the market price of shares of the Fund may
vary substantially from the net asset value per share of the Fund or the level of the share underlying index.
For all of the foregoing reasons,
the performance of the Fund may not correlate with the performance of the share underlying index, the performance of the component
securities of the share underlying index or the net asset value per share of the Fund. Any of these events could materially
and adversely affect the price of the shares of the Fund and, therefore, the value of the Buffered PLUS. Additionally, if
market volatility or these events were to occur on the valuation date, the calculation agent would maintain discretion to determine
whether such market volatility or events have caused a market disruption event to occur, and such determination would affect the
payment at maturity of the Buffered PLUS. If the calculation agent determines that no market disruption event has taken place,
the payment at maturity would be based solely on the published closing price per share of the Fund on the valuation date, even
if the Fund’s shares are underperforming the share underlying index or the component securities of the share underlying index
and/or trading below the net asset value per share of the Fund.
|
§
|
The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate
implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated
with issuing, selling, structuring and hedging the Buffered PLUS in
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
the original issue price reduce
the economic terms of the Buffered PLUS, cause the estimated value of the Buffered PLUS to be less than the original issue price
and will adversely affect secondary market prices.
Assuming no change in market conditions or any other relevant factors, the
prices, if any, at which dealers, including MS & Co., may be willing to purchase the Buffered PLUS in secondary market transactions
will likely be significantly lower than the original issue price, because secondary market prices will exclude the issuing, selling,
structuring and hedging-related costs that are included in the original issue price and borne by you and because the secondary
market prices will reflect our secondary market credit spreads and the bid-offer spread that any dealer would charge in a secondary
market transaction of this type as well as other factors.
The inclusion of the costs of issuing,
selling, structuring and hedging the Buffered PLUS in the original issue price and the lower rate we are willing to pay as issuer
make the economic terms of the Buffered PLUS less favorable to you than they otherwise would be.
However, because the costs associated
with issuing, selling, structuring and hedging the Buffered PLUS are not fully deducted upon issuance, for a period of up to 6
months following the issue date, to the extent that MS & Co. may buy or sell the Buffered PLUS in the secondary market, absent
changes in market conditions, including those related to the underlying shares, and to our secondary market credit spreads, it
would do so based on values higher than the estimated value, and we expect that those higher values will also be reflected in your
brokerage account statements.
|
§
|
The estimated value of the Buffered PLUS is determined by reference to our pricing and valuation models, which may differ
from those of other dealers and is not a maximum or minimum secondary market price.
These pricing and valuation models are
proprietary and rely in part on subjective views of certain market inputs and certain assumptions about future events, which may
prove to be incorrect. As a result, because there is no market-standard way to value these types of securities, our models may
yield a higher estimated value of the Buffered PLUS than those generated by others, including other dealers in the market, if they
attempted to value the Buffered PLUS. In addition, the estimated value on the pricing date does not represent a minimum or maximum
price at which dealers, including MS & Co., would be willing to purchase your Buffered PLUS in the secondary market (if any
exists) at any time. The value of your Buffered PLUS at any time after the date of this document will vary based on many factors
that cannot be predicted with accuracy, including our creditworthiness and changes in market conditions. See also “The market
price of the Buffered PLUS will be influenced by many unpredictable factors” above.
|
|
§
|
The antidilution adjustments the calculation agent is required to make do not cover every event that could affect the shares
of the iShares
®
MSCI Emerging Markets ETF
. MS & Co., as calculation agent, will adjust the amount payable
at maturity for certain events affecting the shares of the
iShares
®
MSCI Emerging
Markets ETF
. However, the calculation agent will not make an adjustment for every event that could affect the shares of
the
iShares
®
MSCI Emerging Markets ETF
. If an event occurs that does not
require the calculation agent to adjust the adjustment factor, the market price of the Buffered PLUS may be materially and adversely
affected.
|
|
§
|
The Buffered PLUS will not be listed on any securities exchange and secondary trading may be limited.
The Buffered PLUS
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the Buffered PLUS. MS
& Co. may, but is not obligated to, make a market in the Buffered PLUS and, if it once chooses to make a market, may cease
doing so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at
prices based on its estimate of the current value of the Buffered PLUS, taking into account its bid/offer spread, our credit spreads,
market volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time remaining
to maturity and the likelihood that it will be able to resell the Buffered PLUS. Even if there is a secondary market, it may not
provide enough liquidity to allow you to trade or sell the Buffered PLUS easily. Since other broker-dealers may not participate
significantly in the secondary market for the Buffered PLUS, the price at which you may be able to trade your Buffered PLUS is
likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease
making a market in the Buffered PLUS, it is likely that there would be no secondary market for the Buffered PLUS. Accordingly,
you should be willing to hold your Buffered PLUS to maturity.
|
|
§
|
The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect
to the Buffered PLUS.
As calculation agent, MS & Co. has determined the initial share price, will determine the final share
price and will calculate the amount of cash you receive at maturity.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
Moreover, certain determinations
made by MS & Co. in its capacity as calculation agent, may require it to exercise discretion and make subjective judgements,
such as with respect to the occurrence or non-occurrence of market disruption events and the selection of a successor index or
calculation of the final share price in the event of a market disruption event or discontinuance of the
MSCI
Emerging Markets Index
SM
. These potentially
subjective determinations
may adversely affect the payout to you at maturity. For further information regarding these type
of determinations, see “Description of PLUS—Postponement of Valuation Date(s)” and “—Calculation
Agent and Calculations” in the accompanying product supplement. In addition, MS & Co. has determined the estimated value
of the Buffered PLUS on the pricing date.
|
§
|
Hedging and trading activity by our affiliates could potentially adversely affect the value of the Buffered PLUS.
One
or more of our affiliates and/or third-party dealers have carried out, and will continue to carry out, hedging activities related
to the Buffered PLUS (and to other instruments linked to the underlying shares or the MSCI Emerging Markets Index
SM
),
including trading in the underlying shares and in other instruments related to the underlying shares or the MSCI Emerging Markets
Index
SM
. As a result, these entities may be unwinding or adjusting hedge positions
during the term of the Buffered PLUS, and the hedging strategy may involve greater and more frequent dynamic adjustments to the
hedge as the valuation date approaches. Some of our affiliates also trade the underlying shares or the stocks that constitute the
MSCI Emerging Markets Index
SM
and other financial instruments related to the MSCI
Emerging Markets Index
SM
on a regular basis as part of their general broker-dealer
and other businesses. Any of these hedging or trading activities on or prior to June 11, 2019 could have increased the initial
share price, and, therefore, could have increased the price at or above which the shares of the
iShares
®
MSCI Emerging Markets ETF
must close on the valuation date so that investors do not suffer a loss on their initial investment
in the Buffered PLUS. Additionally, such hedging or trading activities during the term of the Buffered PLUS, including on the valuation
date, could adversely affect the closing price of the shares of the
iShares
®
MSCI
Emerging Markets ETF
on the valuation date, and, accordingly, the amount of cash an investor will receive at maturity.
|
|
§
|
The U.S. federal income tax consequences of an investment in the Buffered PLUS are uncertain.
Please read the discussion
under “Additional Information—Tax considerations” in this document and the discussion under “United States
Federal Taxation” in the accompanying product supplement for PLUS (together, the “Tax Disclosure Sections”) concerning
the U.S. federal income tax consequences of an investment in the Buffered PLUS. As discussed in the Tax Disclosure Sections, there
is a substantial risk that the “constructive ownership” rule could apply, in which case all or a portion of any long-term
capital gain recognized by a U.S. Holder could be recharacterized as ordinary income and an interest charge could be imposed. If
the Internal Revenue Service (the “IRS”) were successful in asserting an alternative treatment, the timing and character
of income on the Buffered PLUS might differ significantly from the tax treatment described in the Tax Disclosure Sections. For
example, under one possible treatment, the IRS could seek to recharacterize the Buffered PLUS as debt instruments. In that event,
U.S. Holders would be required to accrue into income original issue discount on the Buffered PLUS every year at a “comparable
yield” determined at the time of issuance and recognize all income and gain in respect of the Buffered PLUS as ordinary income.
Additionally, as discussed under “United States Federal Taxation—FATCA” in the accompanying product supplement
for PLUS, the withholding rules commonly referred to as “FATCA” would apply to the Buffered PLUS if they were recharacterized
as debt instruments. However, recently proposed regulations (the preamble to which specifies that taxpayers are permitted to rely
on them pending finalization) eliminate the withholding requirement on payments of gross proceeds of a taxable disposition. The
risk that financial instruments providing for buffers, triggers or similar downside protection features, such as the Buffered PLUS,
would be recharacterized as debt is greater than the risk of recharacterization for comparable financial instruments that do not
have such features. We do not plan to request a ruling from the IRS regarding the tax treatment of the Buffered PLUS, and the IRS
or a court may not agree with the tax treatment described in the Tax Disclosure Sections.
|
In 2007, the U.S. Treasury Department
and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts”
and similar instruments. The notice focuses in particular on whether to require holders of these instruments to accrue income over
the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss
with respect to these instruments; whether short-term instruments should be subject to any such accrual regime; the relevance of
factors such as the exchange-traded status of the instruments and the nature of the underlying property to which the instruments
are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject
to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” rule, as
discussed in this document. While the notice requests comments on appropriate transition rules and effective dates, any Treasury
regulations or other guidance promulgated after consideration of
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
these issues could materially and
adversely affect the tax consequences of an investment in the Buffered PLUS, possibly with retroactive effect. Both U.S. and Non-U.S.
Holders should consult their tax advisers regarding the U.S. federal income tax consequences of an investment in the Buffered PLUS,
including possible alternative treatments, the potential application of the constructive ownership rule, the issues presented by
this notice and any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
iShares
®
MSCI Emerging Markets
ETF Overview
The iShares
®
MSCI Emerging Markets ETF is an exchange-traded
fund that seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the
MSCI Emerging Markets Index
SM
. The iShares
®
MSCI Emerging Markets ETF is managed by iShares
®
,
Inc. (“iShares”), a registered investment company that consists of numerous separate investment portfolios, including
the iShares
®
MSCI Emerging Markets ETF. Information provided to or filed with the Securities and Exchange Commission
(the “Commission”) by iShares pursuant to the Securities Act of 1933 and the Investment Company Act of 1940 can be
located by reference to Commission file numbers 033-97598 and 811-09102, respectively, through the Commission’s website at
www.sec.gov. In addition, information may be obtained from other publicly available sources.
Neither the issuer nor the agent
makes any representation that any such publicly available information regarding the iShares
®
MSCI Emerging Markets
ETF is accurate or complete.
Information as of market close on June 12, 2019:
Bloomberg
Ticker Symbol:
|
EEM UP
|
Current Share
Price:
|
$41.63
|
52 Weeks Ago:
|
$46.21
|
52 Week High
(on 6/12/2018):
|
$46.21
|
52 Week Low
(on 10/29/2018):
|
$38.00
|
The following graph sets forth
the daily closing price of the underlying shares for the period from January 1, 2014 through June 12, 2019. The related table sets
forth the published high and low closing prices as well as the end-of-quarter closing prices of the underlying shares for each
quarter in the same period. The closing price of the underlying shares on June 12, 2019 was $41.63. We obtained the information
in the table and graph below from Bloomberg Financial Markets, without independent verification. The historical prices of the underlying
shares should not be taken as an indication of future performance, and no assurance can be given as to the closing price of the
underlying shares on the valuation date
Shares of the iShares
®
MSCI Emerging Markets ETF
Daily Closing Prices
January 1, 2014 to June 12, 2019
|
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
iShares
®
MSCI Emerging Markets ETF (CUSIP 464287234)
|
High
($)
|
Low
($)
|
Period
End ($)
|
2014
|
|
|
|
First Quarter
|
40.99
|
37.09
|
40.99
|
Second
Quarter
|
43.95
|
40.82
|
43.23
|
Third Quarter
|
45.85
|
41.56
|
41.56
|
Fourth Quarter
|
42.44
|
37.73
|
39.29
|
2015
|
|
|
|
First Quarter
|
41.07
|
37.92
|
40.13
|
Second
Quarter
|
44.09
|
39.04
|
39.62
|
Third Quarter
|
39.78
|
31.32
|
32.78
|
Fourth Quarter
|
36.29
|
31.55
|
32.19
|
2016
|
|
|
|
First Quarter
|
34.28
|
28.25
|
34.25
|
Second Quarter
|
35.26
|
31.89
|
34.36
|
Third Quarter
|
38.20
|
33.77
|
37.45
|
Fourth Quarter
|
38.10
|
34.08
|
35.01
|
2017
|
|
|
|
First Quarter
|
39.99
|
35.43
|
39.39
|
Second Quarter
|
41.93
|
38.81
|
41.39
|
Third Quarter
|
45.85
|
41.05
|
44.81
|
Fourth Quarter
|
47.81
|
44.82
|
47.12
|
2018
|
|
|
|
First Quarter
|
52.08
|
45.69
|
48.28
|
Second Quarter
|
48.14
|
42.33
|
43.33
|
Third Quarter
|
45.03
|
41.14
|
42.92
|
Fourth Quarter
|
42.93
|
38.00
|
39.06
|
2019
|
|
|
|
First Quarter
|
43.71
|
38.45
|
42.92
|
Second Quarter (through June 12, 2019)
|
44.59
|
39.91
|
41.63
|
This document relates only to the Buffered PLUS referenced
hereby and does not relate to the underlying shares. We have derived all disclosures contained in this document regarding iShares
from the publicly available documents described in the preceding paragraph. In connection with the offering of the Buffered PLUS,
neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to
iShares. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available
information regarding iShares is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior
to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described
in the preceding paragraph) that would affect the trading price of the underlying shares (and therefore the price of the underlying
shares at the time we priced the Buffered PLUS) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure
of or failure to disclose material future events concerning iShares could affect the value received at maturity with respect to
the Buffered PLUS and therefore the value of the Buffered PLUS.
Neither we nor any of our affiliates makes any representation
to you as to the performance of the underlying shares.
We and/or our affiliates may presently or from time to time engage
in business with iShares. In the course of such business, we and/or our affiliates may acquire non-public information with respect
to iShares, and neither we nor any of our affiliates undertakes to disclose any such information to you. In addition, one or more
of our affiliates may publish research reports with respect to the underlying shares. The statements in the preceding two sentences
are not intended to affect the rights of investors in the Buffered PLUS under the securities laws. As a purchaser of the Buffered
PLUS, you should undertake an independent investigation of iShares as in your judgment is appropriate to make an informed decision
with respect to an investment linked to the underlying shares.
iShares
®
is a registered trademark of BlackRock
Institutional Trust Company, N.A. (“BTC”). The Buffered PLUS are not sponsored, endorsed, sold, or promoted by BTC.
BTC makes no representations or warranties to the owners of
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
the Buffered PLUS or any member of the public regarding the
advisability of investing in the Buffered PLUS. BTC has no obligation or liability in connection with the operation, marketing,
trading or sale of the Buffered PLUS.
The MSCI Emerging
Markets Index
SM
.
The MSCI Emerging Markets Index
SM
is a stock index
calculated, published and disseminated daily by MSCI Inc. and is intended to provide performance benchmarks for certain emerging
equity markets including Brazil, Chile, China, Colombia, Czech Republic, Egypt, Greece, Hungary, India, Indonesia, Korea, Malaysia,
Mexico, Pakistan, Peru, Philippines, Poland, Qatar, Russia, South Africa, Taiwan, Thailand, Turkey and United Arab Emirates. The
MSCI Emerging Markets Index
SM
is described in “MSCI Emerging Markets Index
SM
” and “MSCI
Global Investable Market Indices Methodology” in the accompanying index supplement.
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
Additional Terms of the Buffered PLUS
Please read this information
in conjunction with the summary terms on the front cover of this document.
Additional
Terms:
|
|
If the terms described herein are inconsistent with those described in the accompanying product supplement, index supplement or prospectus, the terms described herein shall control.
|
Share underlying index:
|
The MSCI Emerging Markets Index
SM
|
Share underlying index publisher:
|
MSCI Inc. or any successor thereof
|
Postponement of
maturity date:
|
If the scheduled valuation date is not a trading day or if a market disruption event occurs on that day so that the valuation date as postponed falls less than two business days prior to the scheduled maturity date, the maturity date of the Buffered PLUS will be postponed to the second business day following that valuation date as postponed.
|
Denominations:
|
$1,000 per Buffered PLUS and integral multiples thereof
|
Trustee:
|
The Bank of New York Mellon
|
Calculation agent:
|
MS & Co.
|
Issuer notice to registered security holders, the trustee and the depositary:
|
In the event that the maturity date is postponed
due to postponement of the valuation date, the issuer shall give notice of such postponement and, once it has been determined,
of the date to which the maturity date has been rescheduled (i) to each registered holder of the Buffered PLUS by mailing notice
of such postponement by first class mail, postage prepaid, to such registered holder’s last address as it shall appear upon
the registry books, (ii) to the trustee by facsimile confirmed by mailing such notice to the trustee by first class mail, postage
prepaid, at its New York office and (iii) to The Depository Trust Company (the “depositary”) by telephone or facsimile,
confirmed by mailing such notice to the depositary by first class mail, postage prepaid. Any notice that is mailed to a registered
holder of the Buffered PLUS in the manner herein provided shall be conclusively presumed to have been duly given to such registered
holder, whether or not such registered holder receives the notice. The issuer shall give such notice as promptly as possible, and
in no case later than (i) with respect to notice of postponement of the maturity date, the business day immediately preceding the
scheduled maturity date and (ii) with respect to notice of the date to which the maturity date has been rescheduled, the business
day immediately following the actual valuation date.
The issuer shall, or shall cause the calculation
agent to, (i) provide written notice to the trustee and to the depositary of the amount of cash to be delivered with respect to
each stated principal amount of the Buffered PLUS, on or prior to 10:30 a.m. (New York City time) on the business day preceding
the maturity date, and (ii) deliver the aggregate cash amount due with respect to the Buffered PLUS to the trustee for delivery
to the depositary, as holder of the Buffered PLUS, on the maturity date.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares
®
MSCI Emerging Markets ETF due June 16, 2021
Buffered Performance Leveraged Upside Securities
SM
Principal at Risk Securities
Additional Information About the Buffered PLUS